UiPath (NYSE:PATH – Free Report) had its target price decreased by Canaccord Genuity Group from $17.00 to $14.00 in a research report sent to investors on Thursday, Marketbeat.com reports. Canaccord Genuity Group currently has a hold rating on the stock.
A number of other equities research analysts have also issued reports on the company. Wells Fargo & Company boosted their target price on UiPath from $13.00 to $15.00 and gave the stock an “equal weight” rating in a research report on Friday, September 4th. Barclays lifted their price target on UiPath from $14.00 to $17.00 and gave the stock an “equal weight” rating in a research note on Friday, September 4th. Truist Financial cut their price objective on UiPath from $17.00 to $14.00 and set a “hold” rating on the stock in a report on Wednesday. HC Wainwright reaffirmed a “buy” rating on shares of UiPath in a research note on Friday, September 4th. Finally, Citigroup began coverage on shares of UiPath in a report on Tuesday, September 8th. They issued a “buy” rating and a $23.00 target price for the company. Four research analysts have rated the stock with a Buy rating, sixteen have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, UiPath has a consensus rating of “Hold” and an average target price of $16.06.
Read Our Latest Stock Analysis on PATH
UiPath Stock Performance
UiPath (NYSE:PATH – Get Free Report) last announced its quarterly earnings data on Thursday, September 3rd. The company reported $0.15 EPS for the quarter, meeting analysts’ consensus estimates of $0.15. The company had revenue of $410.26 million during the quarter, compared to the consensus estimate of $397.77 million. UiPath had a return on equity of 9.70% and a net margin of 21.03%.The company’s quarterly revenue was up 13.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.15 EPS. As a group, equities analysts predict that UiPath will post 0.49 EPS for the current fiscal year.
Insider Transactions at UiPath
In other news, CEO Daniel Dines sold 1,402,347 shares of UiPath stock in a transaction on Wednesday, August 19th. The stock was sold at an average price of $16.07, for a total transaction of $22,535,716.29. Following the transaction, the chief executive officer owned 26,491,238 shares in the company, valued at approximately $425,714,194.66. The trade was a 5.03% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, COO Ashim Gupta sold 117,339 shares of the company’s stock in a transaction on Friday, September 11th. The shares were sold at an average price of $13.85, for a total value of $1,625,145.15. Following the transaction, the chief operating officer directly owned 2,037,377 shares in the company, valued at $28,217,671.45. The trade was a 5.45% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 1,560,150 shares of company stock valued at $24,727,357 over the last quarter. Company insiders own 22.44% of the company’s stock.
Institutional Trading of UiPath
Several institutional investors have recently made changes to their positions in PATH. QRG Capital Management Inc. grew its position in UiPath by 26.6% during the second quarter. QRG Capital Management Inc. now owns 33,866 shares of the company’s stock valued at $368,000 after purchasing an additional 7,120 shares in the last quarter. Envestnet Asset Management Inc. lifted its position in UiPath by 56.0% in the 2nd quarter. Envestnet Asset Management Inc. now owns 69,078 shares of the company’s stock worth $751,000 after buying an additional 24,807 shares in the last quarter. State Street Corp boosted its stake in shares of UiPath by 3.6% during the 2nd quarter. State Street Corp now owns 13,832,188 shares of the company’s stock valued at $150,356,000 after buying an additional 486,007 shares during the period. Sequoia Financial Advisors LLC boosted its stake in shares of UiPath by 59.4% during the 2nd quarter. Sequoia Financial Advisors LLC now owns 38,545 shares of the company’s stock valued at $419,000 after buying an additional 14,361 shares during the period. Finally, Tidal Investments LLC grew its holdings in shares of UiPath by 24.4% during the 2nd quarter. Tidal Investments LLC now owns 794,084 shares of the company’s stock valued at $8,632,000 after acquiring an additional 155,521 shares in the last quarter. 62.50% of the stock is currently owned by institutional investors and hedge funds.
More UiPath News
Here are the key news stories impacting UiPath this week:
- Positive Sentiment: UiPath customer adoption is demonstrating real-world demand for agentic automation, with one customer reportedly processing approximately 100,000 medical billing cases per week. This supports the company’s case that its technology can deliver measurable productivity gains at enterprise scale. Accountable intelligence – how a UiPath customer is using agentic automation to process 100,000 medical billing cases a week
- Positive Sentiment: The company introduced Cartographer and additional workflow automation and software-testing capabilities intended to connect business processes, software agents and enterprise AI orchestration. These tools could expand UiPath’s addressable market if they accelerate customer adoption. UiPath’s new tool could unlock a much bigger wave of automated business processes
- Positive Sentiment: UiPath announced the 2026 GeekWire AI Breakthrough Award winners, showcasing enterprises using agentic AI in production. The recognition may improve market visibility and reinforce the company’s positioning in enterprise AI. UiPath Announces Winners of the 2026 Geekwire AI Breakthrough Awards
- Neutral Sentiment: Needham reaffirmed its Buy rating, while Barclays and TD Cowen maintained Hold ratings, indicating mixed Wall Street conviction rather than a clear consensus. Needham reaffirms Buy rating
- Negative Sentiment: BMO Capital Markets cut its price target from $18 to $15 and Canaccord Genuity reduced its target from $17 to $14; both firms now carry middle-ground ratings. UBS also lowered its target, adding to investor concerns about UiPath’s near-term upside. Why UiPath stock is down today
- Negative Sentiment: The stock’s decline was compounded by rising Treasury yields and a broader software-sector selloff. Although annual recurring revenue reached $1.938 billion, investors appeared focused on valuation pressure and the shares’ persistent monthly downtrend. UiPath stock falls as ARR reaches $1.938 billion
UiPath Company Profile
UiPath Inc (NYSE: PATH) develops enterprise automation software designed to help organizations automate repetitive, rules-based and increasingly complex business processes. Its platform combines robotic process automation (RPA), artificial intelligence, workflow orchestration and process intelligence to support automation across areas such as finance, customer service, human resources, information technology and operations.
The UiPath Platform includes tools for discovering and analyzing business processes, building and managing software robots, processing documents, testing applications and coordinating automated workflows.
Read More
- Five stocks we like better than UiPath
- 3 Defense Stocks Riding Nuclear, Missile, and Aerospace Demand
- SoFi Is Bypassing the Banking Bottleneck With Stablecoin Settlement
- These 3 Overlooked Stocks Have Big Money Behind Them
- Darden Restaurants Serves Up Fresh Catalysts for a Stock Price Rally
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.
